Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > Ezine Publishing > Don't Distract Readers from What They are Doing

Tags

  • maximize
  • surrounding
  • services
  • clear about

  • Links

  • Anthony Robbins' 12 Reasons Why People Don't Get Wealthy
  • Computer Graphic Schools Foster Dynamically Digital Careers
  • Looking for Bermuda Grass Maintenance Tips?
  • Main Subject - Don't Distract Readers from What They are Doing

    I’m working on a report for a company that puts out a newsletter on a monthly basis.

    Their open rate and clickthrough rate are some
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    what above industry averages. But I still wonder if they could do better.

    Here’s what’s happening. Their newsletters have a purpose
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    . Each issue promotes various services and provides links to more information on their site. And the writing is excellent. The tone
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    is both personal and informative. The text is engaging, respectful and does a great job of building interest and then providing a cl
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ear, descriptive link forward.

    So what’s the problem?

    The problem is that I think a great deal of their clickthrough is derived no
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    t from these links to the services they are selling. I think much of the clickthrough comes from other links on the page.

    Let me ex
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    plain. All this great copy is surrounded by dozens of other links and clickable images to other parts of the site, few of which are
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    directly related to the services being promoted.

    The layout of the newsletter is a little like a web page. At the top and to the le
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ft of the first screen of the newsletter, about ten different links shout out for your attention.

    In other words, the central conte
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    nt of the newsletter is great, but the surrounding elements are hugely distracting.

    If the purpose of the newsletter is simply to g
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    nerate as many clickthroughs to the site as possible, regardless of the landing page, then there’s no problem. But I don’t think thi
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    s is the case. I think the purpose is to maximize the number of people who click through the links that are within the central conte
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    nt of the newsletter.

    If I’m right, then they need to do a little redesigning and remove most of the elements that might distract p
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    eople from the content they want to read.

    And this is not found only within newsletters. The same problem can be found on many web
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    site pages. You’ll be on a second or third-level page, well on your way towards achieving the task you have in mind, and suddenly yo
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    u’ll find your attention being distracted by links, ads and offers unrelated to that task.

    In short, be clear about your purpose an
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    d about what you want your visitors to do at any one point on your site.

    And ask yourself, if people are just one click away from c
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ompleting their task, do you really want to distract them by surrounding the central content with other, unrelated links?

    And if yo
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    u are publishing a newsletter, do you just want clickthroughs? Or do you want people to click through on the products or services yo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    u are highlighting in that particular issue?

    Be clear about your purpose, and don’t allow unrelated elements to create distractions


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/63659/mainsubjects-Dont-Distract-Readers-from-What-They-are-Doing.html">Don't Distract Readers from What They are Doing</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/63659/mainsubjects-Dont-Distract-Readers-from-What-They-are-Doing.html]Don't Distract Readers from What They are Doing[/url]

    Related Articles:

    What To Look For In A Burbank Mold Inspector

    Affiliate Marketing - 2 Methods of Email Copy Formula

    Which eBay Checkout Program is For You?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com